TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/20/23 16:14 | 1/19/23 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | M.d | 39 | 1.37 | 0 | 28 | 10 | 311 | D | ||||||||||||||||
1/13/23 18:20 | 1/11/23 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | P.m | 698 | 5.60 | 0 | 125 | 79 | 283 | D | ||||||||||||||||
6/6/22 16:49 | 6/3/22 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | S | -31 | 22.79 | 0 | -1 | -1 | 158 | D | ||||||||||||||||
3/11/22 16:58 | 3/10/22 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | M.d | 51 | 1.63 | 0 | 32 | 25 | 159 | D | ||||||||||||||||
3/11/22 16:58 | 3/10/22 | FATE | Fate Therapeutics Inc | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | S.d | -1,105 | 35.02 | 0 | -32 | -17 | 159 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |